Cargando…
Indian pharma threatened by COVID-19 shutdowns in China
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137871/ https://www.ncbi.nlm.nih.gov/pubmed/32113494 http://dx.doi.org/10.1016/S0140-6736(20)30459-1 |
| _version_ | 1783518493058007040 |
|---|---|
| author | Chatterjee, Patralekha |
| author_facet | Chatterjee, Patralekha |
| author_sort | Chatterjee, Patralekha |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7137871 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71378712020-04-08 Indian pharma threatened by COVID-19 shutdowns in China Chatterjee, Patralekha Lancet World Report Elsevier Ltd. 2020 2020-02-27 /pmc/articles/PMC7137871/ /pubmed/32113494 http://dx.doi.org/10.1016/S0140-6736(20)30459-1 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | World Report Chatterjee, Patralekha Indian pharma threatened by COVID-19 shutdowns in China |
| title | Indian pharma threatened by COVID-19 shutdowns in China |
| title_full | Indian pharma threatened by COVID-19 shutdowns in China |
| title_fullStr | Indian pharma threatened by COVID-19 shutdowns in China |
| title_full_unstemmed | Indian pharma threatened by COVID-19 shutdowns in China |
| title_short | Indian pharma threatened by COVID-19 shutdowns in China |
| title_sort | indian pharma threatened by covid-19 shutdowns in china |
| topic | World Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137871/ https://www.ncbi.nlm.nih.gov/pubmed/32113494 http://dx.doi.org/10.1016/S0140-6736(20)30459-1 |
| work_keys_str_mv | AT chatterjeepatralekha indianpharmathreatenedbycovid19shutdownsinchina |